This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakshatri, H.
Right arrow Articles by Sledge, G. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakshatri, H.
Right arrow Articles by Sledge, G. W., Jr

 Previous Article  |  Next Article 

Mol. Cell. Biol., Jul 1997, 3629-3639, Vol 17, No. 7
Copyright © 1997, American Society for Microbiology

Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth

H Nakshatri, P Bhat-Nakshatri, DA Martin, RJ Goulet Jr and GW Sledge Jr
Department of Surgery, Indiana University School of Medicine, Indianapolis 46202, USA. Harikrishna_Nakshatri@iucc.iupui.edu

Breast cancers often progress from a hormone-dependent, nonmetastatic, antiestrogen-sensitive phenotype to a hormone-independent, antiestrogen- and chemotherapy-resistant phenotype with highly invasive and metastatic growth properties. This progression is usually accompanied by altered function of the estrogen receptor (ER) or outgrowth of ER- negative cancer cells. To understand the molecular mechanisms responsible for metastatic growth of ER-negative breast cancers, the activities of the transcription factor NF-kappaB (which modulates the expression of genes involved in cell proliferation, differentiation, apoptosis, and metastasis) were compared in ER-positive (MCF-7 and T47- D) and ER-negative (MDA-MB-231 and MDA-MB-435) human breast cancer cell lines. NF-kappaB, which is usually maintained in an inactive state by protein-protein interaction with inhibitor IkappaBs, was found to be constitutively active in ER-negative breast cancer cell lines. Constitutive DNA binding of NF-kappaB was also observed with extracts from ER-negative, poorly differentiated primary breast tumors. Progression of the rat mammary carcinoma cell line RM22-F5 from an ER- positive, nonmalignant phenotype (E phenotype) to an ER-negative, malignant phenotype (F phenotype) was also accompanied by constitutive activation of NF-kappaB. Analysis of individual subunits of NF-kappaB revealed that all ER-negative cell lines, including RM22-F5 cells of F phenotype, contain a unique 37-kDa protein which is antigenically related to the RelA subunit. Cell-type-specific differences in IkappaB alpha, -beta, and -gamma were also observed. In transient-transfection experiments, constitutive activity of an NF-kappaB-dependent promoter was observed in MDA-MB-231 and RM22-F5 cells of F phenotype, and this activity was efficiently repressed by cotransfected ER. Since ER inhibits the constitutive as well as inducible activation function of NF-kappaB in a dose-dependent manner, we propose that breast cancers that lack functional ER overexpress NF-kappaB-regulated genes. Furthermore, since recent data indicate that NF-kappaB protects cells from tumor necrosis factor alpha-, ionizing radiation-, and chemotherapeutic agent daunorubicin-mediated apoptosis, our results provide an explanation for chemotherapeutic resistance in ER-negative breast cancers.


This article has been cited by other articles:

  • Jogie-Brahim, S., Feldman, D., Oh, Y. (2009). Unraveling Insulin-Like Growth Factor Binding Protein-3 Actions in Human Disease. Endocr. Rev. 30: 417-437 [Abstract] [Full Text]  
  • Zhang, L., Altuwaijri, S., Deng, F., Chen, L., Lal, P., Bhanot, U. K., Korets, R., Wenske, S., Lilja, H. G., Chang, C., Scher, H. I., Gerald, W. L. (2009). NF-{kappa}B Regulates Androgen Receptor Expression and Prostate Cancer Growth. Am. J. Pathol. 175: 489-499 [Abstract] [Full Text]  
  • Wang, X., Belguise, K., O'Neill, C. F., Sanchez-Morgan, N., Romagnoli, M., Eddy, S. F., Mineva, N. D., Yu, Z., Min, C., Trinkaus-Randall, V., Chalbos, D., Sonenshein, G. E. (2009). RelB NF-{kappa}B Represses Estrogen Receptor {alpha} Expression via Induction of the Zinc Finger Protein Blimp1. Mol. Cell. Biol. 29: 3832-3844 [Abstract] [Full Text]  
  • Ban, J. O., Oh, J. H., Hwang, B. Y., Moon, D. C., Jeong, H.-S., Lee, S., Kim, S., Lee, H., Kim, K.-B., Han, S. B., Hong, J. T. (2009). Inflexinol inhibits colon cancer cell growth through inhibition of nuclear factor-{kappa}B activity via direct interaction with p50. Molecular Cancer Therapeutics 8: 1613-1624 [Abstract] [Full Text]  
  • Caldas-Lopes, E., Cerchietti, L., Ahn, J. H., Clement, C. C., Robles, A. I., Rodina, A., Moulick, K., Taldone, T., Gozman, A., Guo, Y., Wu, N., de Stanchina, E., White, J., Gross, S. S., Ma, Y., Varticovski, L., Melnick, A., Chiosis, G. (2009). Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer models. Proc. Natl. Acad. Sci. USA 106: 8368-8373 [Abstract] [Full Text]  
  • Sakamoto, K., Maeda, S., Hikiba, Y., Nakagawa, H., Hayakawa, Y., Shibata, W., Yanai, A., Ogura, K., Omata, M. (2009). Constitutive NF-{kappa}B Activation in Colorectal Carcinoma Plays a Key Role in Angiogenesis, Promoting Tumor Growth. Clin. Cancer Res. 15: 2248-2258 [Abstract] [Full Text]  
  • Bednarski, B. K., Ding, X., Coombe, K., Baldwin, A. S., Kim, H. J. (2008). Active roles for inhibitory {kappa}B kinases {alpha} and {beta} in nuclear factor-{kappa}B-mediated chemoresistance to doxorubicin. Molecular Cancer Therapeutics 7: 1827-1835 [Abstract] [Full Text]  
  • Kijima, I., Ye, J., Glackin, C., Chen, S. (2008). CCAAT/Enhancer Binding Protein {delta} Up-regulates Aromatase Promoters I.3/II in Breast Cancer Epithelial Cells. Cancer Res. 68: 4455-4464 [Abstract] [Full Text]  
  • Renoir, J.-M., Bouclier, C., Seguin, A., Marsaud, V., Sola, B. (2008). Antioestrogen-mediated cell cycle arrest and apoptosis induction in breast cancer and multiple myeloma cells. J Mol Endocrinol 40: 101-112 [Abstract] [Full Text]  
  • Sethi, G., Sung, B., Aggarwal, B. B. (2008). Nuclear Factor-{kappa}B Activation: From Bench to Bedside. Exp. Biol. Med. 233: 21-31 [Abstract] [Full Text]  
  • Braunstein, S., Formenti, S. C., Schneider, R. J. (2008). Acquisition of Stable Inducible Up-Regulation of Nuclear Factor-{kappa}B by Tumor Necrosis Factor Exposure Confers Increased Radiation Resistance without Increased Transformation in Breast Cancer Cells. Mol Cancer Res 6: 78-88 [Abstract] [Full Text]  
  • Bayliss, J., Hilger, A., Vishnu, P., Diehl, K., El-Ashry, D. (2007). Reversal of the Estrogen Receptor Negative Phenotype in Breast Cancer and Restoration of Antiestrogen Response. Clin. Cancer Res. 13: 7029-7036 [Abstract] [Full Text]  
  • Friedland, J. C., Lakins, J. N., Kazanietz, M. G., Chernoff, J., Boettiger, D., Weaver, V. M. (2007). {alpha}6beta4 integrin activates Rac-dependent p21-activated kinase 1 to drive NF-{kappa}B-dependent resistance to apoptosis in 3D mammary acini. J. Cell Sci. 120: 3700-3712 [Abstract] [Full Text]  
  • Sartore-Bianchi, A., Gasparri, F., Galvani, A., Nici, L., Darnowski, J. W., Barbone, D., Fennell, D. A., Gaudino, G., Porta, C., Mutti, L. (2007). Bortezomib Inhibits Nuclear Factor-{kappa}B Dependent Survival and Has Potent In vivo Activity in Mesothelioma. Clin. Cancer Res. 13: 5942-5951 [Abstract] [Full Text]  
  • Guruvayoorappan, C., Kuttan, G. (2007). {beta}-Carotene Inhibits Tumor-Specific Angiogenesis by Altering the Cytokine Profile and Inhibits the Nuclear Translocation of Transcription Factors in B16F-10 Melanoma Cells. Integr Cancer Ther 6: 258-270 [Abstract]  
  • Trauernicht, A. M., Kim, S. J., Kim, N. H., Boyer, T. G. (2007). Modulation of Estrogen Receptor {alpha} Protein Level and Survival Function by DBC-1. Mol. Endocrinol. 21: 1526-1536 [Abstract] [Full Text]  
  • Singh, S., Shi, Q., Bailey, S. T., Palczewski, M. J., Pardee, A. B., Iglehart, J. D., Biswas, D. K. (2007). Nuclear factor-{kappa}B activation: a molecular therapeutic target for estrogen receptor-negative and epidermal growth factor receptor family receptor-positive human breast cancer. Molecular Cancer Therapeutics 6: 1973-1982 [Abstract] [Full Text]  
  • Nasu, K., Nishida, M., Ueda, T., Yuge, A., Takai, N., Narahara, H. (2007). Application of the nuclear factor-{kappa}B inhibitor BAY 11-7085 for the treatment of endometriosis: an in vitro study. Am. J. Physiol. Endocrinol. Metab. 293: E16-E23 [Abstract] [Full Text]  
  • Guruvayoorappan, C., Kuttan, G. (2007). Effect of Amentoflavone on the Inhibition of Pulmonary Metastasis Induced by B16F-10 Melanoma Cells in C57BL/6 Mice. Integr Cancer Ther 6: 185-197 [Abstract]  
  • Yip-Schneider, M. T., Wu, H., Ralstin, M., Yiannoutsos, C., Crooks, P. A., Neelakantan, S., Noble, S., Nakshatri, H., Sweeney, C. J., Schmidt, C. M. (2007). Suppression of pancreatic tumor growth by combination chemotherapy with sulindac and LC-1 is associated with cyclin D1 inhibition in vivo. Molecular Cancer Therapeutics 6: 1736-1744 [Abstract] [Full Text]  
  • Hirano, S., Furutama, D., Hanafusa, T. (2007). Physiologically high concentrations of 17beta-estradiol enhance NF-{kappa}B activity in human T cells. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292: R1465-R1471 [Abstract] [Full Text]  
  • Connelly, L., Robinson-Benion, C., Chont, M., Saint-Jean, L., Li, H., Polosukhin, V. V., Blackwell, T. S., Yull, F. E. (2007). A Transgenic Model Reveals Important Roles for the NF-{kappa}B Alternative Pathway (p100/p52) in Mammary Development and Links to Tumorigenesis. J. Biol. Chem. 282: 10028-10035 [Abstract] [Full Text]  
  • Gupta, V., Yeo, G., Kawakubo, H., Rangnekar, V., Ramaswamy, P., Hayashida, T., MacLaughlin, D. T., Donahoe, P. K., Maheswaran, S. (2007). Mullerian-Inhibiting Substance Induces Gro-{beta} Expression in Breast Cancer Cells through a Nuclear Factor-{kappa}B-Dependent and Smad1-Dependent Mechanism. Cancer Res. 67: 2747-2756 [Abstract] [Full Text]  
  • Briassouli, P., Chan, F., Savage, K., Reis-Filho, J. S., Linardopoulos, S. (2007). Aurora-A Regulation of Nuclear Factor-{kappa}B Signaling by Phosphorylation of I{kappa}B{alpha}. Cancer Res. 67: 1689-1695 [Abstract] [Full Text]  
  • Maroni, P., Bendinelli, P., Matteucci, E., Desiderio, M. A. (2007). HGF induces CXCR4 and CXCL12-mediated tumor invasion through Ets1 and NF-{kappa}B. Carcinogenesis 28: 267-279 [Abstract] [Full Text]  
  • Zhang, J., Warren, M. A., Shoemaker, S. F., Ip, M. M. (2007). NF{kappa}B1/p50 Is Not Required for Tumor Necrosis Factor-Stimulated Growth of Primary Mammary Epithelial Cells: Implications for NF{kappa}B2/p52 and RelB. Endocrinology 148: 268-278 [Abstract] [Full Text]  
  • Kishida, Y., Yoshikawa, H., Myoui, A. (2007). Parthenolide, a Natural Inhibitor of Nuclear Factor-{kappa}B, Inhibits Lung Colonization of Murine Osteosarcoma Cells. Clin. Cancer Res. 13: 59-67 [Abstract] [Full Text]  
  • Loewe, R., Valero, T., Kremling, S., Pratscher, B., Kunstfeld, R., Pehamberger, H., Petzelbauer, P. (2006). Dimethylfumarate Impairs Melanoma Growth and Metastasis. Cancer Res. 66: 11888-11896 [Abstract] [Full Text]  
  • Liu, Y., Smith, P. W., Jones, D. R. (2006). Breast Cancer Metastasis Suppressor 1 Functions as a Corepressor by Enhancing Histone Deacetylase 1-Mediated Deacetylation of RelA/p65 and Promoting Apoptosis. Mol. Cell. Biol. 26: 8683-8696 [Abstract] [Full Text]  
  • Ciucci, A., Gianferretti, P., Piva, R., Guyot, T., Snape, T. J., Roberts, S. M., Santoro, M. G. (2006). Induction of Apoptosis in Estrogen Receptor-Negative Breast Cancer Cells by Natural and Synthetic Cyclopentenones: Role of the I{kappa}B Kinase/Nuclear Factor-{kappa}B Pathway. Mol. Pharmacol. 70: 1812-1821 [Abstract] [Full Text]  
  • Mann, A. P., Verma, A., Sethi, G., Manavathi, B., Wang, H., Fok, J. Y., Kunnumakkara, A. B., Kumar, R., Aggarwal, B. B., Mehta, K. (2006). Overexpression of Tissue Transglutaminase Leads to Constitutive Activation of Nuclear Factor-{kappa}B in Cancer Cells: Delineation of a Novel Pathway.. Cancer Res. 66: 8788-8795 [Abstract] [Full Text]  
  • Horiguchi, K., Arai, S., Nishihara, T., Nishikawa, J.-i. (2006). AIB1 Promotes DNA Replication by JNK Repression and AKT Activation during Cellular Stress. J Biochem 140: 409-419 [Abstract] [Full Text]  
  • Lin, X., Yu, Y., Zhao, H., Zhang, Y., Manela, J., Tonetti, D. A. (2006). Overexpression of PKC{alpha} is required to impart estradiol inhibition and tamoxifen-resistance in a T47D human breast cancer tumor model. Carcinogenesis 27: 1538-1546 [Abstract] [Full Text]  
  • Lacroix, M., Toillon, R.-A., Leclercq, G. (2006). p53 and breast cancer, an update.. Endocr Relat Cancer 13: 293-325 [Abstract] [Full Text]  
  • Montagut, C, Tusquets, I, Ferrer, B, Corominas, J M, Bellosillo, B, Campas, C, Suarez, M, Fabregat, X, Campo, E, Gascon, P, Serrano, S, Fernandez, P L, Rovira, A, Albanell, J (2006). Activation of nuclear factor-{kappa} B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients.. Endocr Relat Cancer 13: 607-616 [Abstract] [Full Text]  
  • Ralstin, M. C., Gage, E. A., Yip-Schneider, M. T., Klein, P. J., Wiebke, E. A., Schmidt, C. M. (2006). Parthenolide Cooperates with NS398 to Inhibit Growth of Human Hepatocellular Carcinoma Cells through Effects on Apoptosis and G0-G1 Cell Cycle Arrest. Mol Cancer Res 4: 387-399 [Abstract] [Full Text]  
  • Van Laere, S. J., Van der Auwera, I., Van den Eynden, G. G., Elst, H. J., Weyler, J., Harris, A. L., van Dam, P., Van Marck, E. A., Vermeulen, P. B., Dirix, L. Y. (2006). Nuclear Factor-{kappa}B Signature of Inflammatory Breast Cancer by cDNA Microarray Validated by Quantitative Real-time Reverse Transcription-PCR, Immunohistochemistry, and Nuclear Factor-{kappa}B DNA-Binding.. Clin. Cancer Res. 12: 3249-3256 [Abstract] [Full Text]  
  • Imre, G., Gekeler, V., Leja, A., Beckers, T., Boehm, M. (2006). Histone Deacetylase Inhibitors Suppress the Inducibility of Nuclear Factor-{kappa}B by Tumor Necrosis Factor-{alpha} Receptor-1 Down-regulation.. Cancer Res. 66: 5409-5418 [Abstract] [Full Text]  
  • Heon Seo, K., Ko, H.-M., Kim, H.-A, Choi, J.-H., Jun Park, S., Kim, K.-J., Lee, H.-K., Im, S.-Y. (2006). Platelet-Activating Factor Induces Up-regulation of Antiapoptotic Factors in a Melanoma Cell Line through Nuclear Factor-{kappa}B Activation.. Cancer Res. 66: 4681-4686 [Abstract] [Full Text]  
  • Vanden Berghe, W., Dijsselbloem, N., Vermeulen, L., Ndlovu, M. N., Boone, E., Haegeman, G. (2006). Attenuation of Mitogen- and Stress-Activated Protein Kinase-1-Driven Nuclear Factor-{kappa}B Gene Expression by Soy Isoflavones Does Not Require Estrogenic Activity.. Cancer Res. 66: 4852-4862 [Abstract] [Full Text]  
  • Shin, S. R., Sanchez-Velar, N., Sherr, D. H., Sonenshein, G. E. (2006). 7,12-Dimethylbenz(a)Anthracene Treatment of a c-rel Mouse Mammary Tumor Cell Line Induces Epithelial to Mesenchymal Transition via Activation of Nuclear Factor-{kappa}B.. Cancer Res. 66: 2570-2575 [Abstract] [Full Text]  
  • Kim, N.-S., Kim, H.-J., Koo, B.-K., Kwon, M.-C., Kim, Y.-W., Cho, Y., Yokota, Y., Penninger, J. M., Kong, Y.-Y. (2006). Receptor Activator of NF-{kappa}B Ligand Regulates the Proliferation of Mammary Epithelial Cells via Id2. Mol. Cell. Biol. 26: 1002-1013 [Abstract] [Full Text]  
  • Ichikawa, H., Aggarwal, B. B. (2006). Guggulsterone Inhibits Osteoclastogenesis Induced by Receptor Activator of Nuclear Factor-{kappa}B Ligand and by Tumor Cells by Suppressing Nuclear Factor-{kappa}B Activation. Clin. Cancer Res. 12: 662-668 [Abstract] [Full Text]  
  • Tanaka, A., Muto, S., Konno, M., Itai, A., Matsuda, H. (2006). A New I{kappa}B Kinase {beta} Inhibitor Prevents Human Breast Cancer Progression through Negative Regulation of Cell Cycle Transition. Cancer Res. 66: 419-426 [Abstract] [Full Text]  
  • Chapman, N. R., Kennelly, M. M., Harper, K. A., Europe-Finner, G. N., Robson, S. C. (2006). Examining the spatio-temporal expression of mRNA encoding the membrane-bound progesterone receptor-alpha isoform in human cervix and myometrium during pregnancy and labour. Mol Hum Reprod 12: 19-24 [Abstract] [Full Text]  
  • Eddy, S. F., Guo, S., Demicco, E. G., Romieu-Mourez, R., Landesman-Bollag, E., Seldin, D. C., Sonenshein, G. E. (2005). Inducible I{kappa}B Kinase/I{kappa}B Kinase {varepsilon} Expression Is Induced by CK2 and Promotes Aberrant Nuclear Factor-{kappa}B Activation in Breast Cancer Cells. Cancer Res. 65: 11375-11383 [Abstract] [Full Text]  
  • Modugno, F., Ness, R. B., Chen, C., Weiss, N. S. (2005). Inflammation and Endometrial Cancer: A Hypothesis. Cancer Epidemiol. Biomarkers Prev. 14: 2840-2847 [Abstract] [Full Text]  
  • Demicco, E. G., Kavanagh, K. T., Romieu-Mourez, R., Wang, X., Shin, S. R., Landesman-Bollag, E., Seldin, D. C., Sonenshein, G. E. (2005). RelB/p52 NF-{kappa}B Complexes Rescue an Early Delay in Mammary Gland Development in Transgenic Mice with Targeted Superrepressor I{kappa}B-{alpha} Expression and Promote Carcinogenesis of the Mammary Gland. Mol. Cell. Biol. 25: 10136-10147 [Abstract] [Full Text]  
  • Aggarwal, B. B., Shishodia, S., Takada, Y., Banerjee, S., Newman, R. A., Bueso-Ramos, C. E., Price, J. E. (2005). Curcumin Suppresses the Paclitaxel-Induced Nuclear Factor-{kappa}B Pathway in Breast Cancer Cells and Inhibits Lung Metastasis of Human Breast Cancer in Nude Mice. Clin. Cancer Res. 11: 7490-7498 [Abstract] [Full Text]  
  • Berchtold, C. M., Chen, K.-S., Miyamoto, S., Gould, M. N. (2005). Perillyl Alcohol Inhibits a Calcium-Dependent Constitutive Nuclear Factor-{kappa}B Pathway. Cancer Res. 65: 8558-8566 [Abstract] [Full Text]  
  • Rau, K-M, Kang, H-Y, Cha, T-L, Miller, S A, Hung, M-C (2005). The mechanisms and managements of hormone-therapy resistance in breast and prostate cancers. Endocr Relat Cancer 12: 511-532 [Abstract] [Full Text]  
  • Kim, B. Y., Kim, K. A., Kwon, O., Kim, S. O., Kim, M. S., Kim, B. S., Oh, W. K., Kim, G. D., Jung, M., Ahn, J. S. (2005). NF-{kappa}B inhibition radiosensitizes Ki-Ras-transformed cells to ionizing radiation. Carcinogenesis 26: 1395-1403 [Abstract] [Full Text]  
  • Cavin, L. G., Wang, F., Factor, V. M., Kaur, S., Venkatraman, M., Thorgeirsson, S. S., Arsura, M. (2005). Transforming Growth Factor-{alpha} Inhibits the Intrinsic Pathway of c-Myc-Induced Apoptosis through Activation of Nuclear Factor-{kappa}B in Murine Hepatocellular Carcinomas. Mol Cancer Res 3: 403-412 [Abstract] [Full Text]  
  • Zhou, Y, Eppenberger-Castori, S, Eppenberger, U, Benz, C C (2005). The NF{kappa}B pathway and endocrine-resistant breast cancer. Endocr Relat Cancer 12: S37-S46 [Abstract] [Full Text]  
  • Biswas, D. K., Singh, S., Shi, Q., Pardee, A. B., Iglehart, J. D. (2005). Crossroads of Estrogen Receptor and NF-{kappa}B Signaling. Sci Signal 2005: pe27-pe27 [Abstract] [Full Text]  
  • Cicek, M., Fukuyama, R., Welch, D. R., Sizemore, N., Casey, G. (2005). Breast Cancer Metastasis Suppressor 1 Inhibits Gene Expression by Targeting Nuclear Factor-{kappa}B Activity. Cancer Res. 65: 3586-3595 [Abstract] [Full Text]  
  • Shah, S. J., Sylvester, P. W. (2005). {gamma}-Tocotrienol Inhibits Neoplastic Mammary Epithelial Cell Proliferation by Decreasing Akt and Nuclear Factor {kappa}B Activity. Exp. Biol. Med. 230: 235-241 [Abstract] [Full Text]  
  • Yip-Schneider, M. T., Nakshatri, H., Sweeney, C. J., Marshall, M. S., Wiebke, E. A., Schmidt, C. M. (2005). Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-{kappa}B pathway in pancreatic carcinoma cells. Molecular Cancer Therapeutics 4: 587-594 [Abstract] [Full Text]  
  • Park, S. W., Huq, M. D.M., Hu, X., Wei, L.-N. (2005). Tyrosine Nitration on p65: A Novel Mechanism to Rapidly Inactivate Nuclear Factor-{kappa}B. Mol. Cell. Proteomics 4: 300-309 [Abstract] [Full Text]  
  • Preciado, D., Caicedo, E., Jhanjee, R., Silver, R., Harris, G., Juhn, S. K., Choo, D. I., Ondrey, F. (2005). Pseudomonas aeruginosa Lipopolysaccharide Induction of Keratinocyte Proliferation, NF-{kappa}B, and Cyclin D1 Is Inhibited by Indomethacin. J. Immunol. 174: 2964-2973 [Abstract] [Full Text]  
  • Matsumoto, G., Namekawa, J.-i., Muta, M., Nakamura, T., Bando, H., Tohyama, K., Toi, M., Umezawa, K. (2005). Targeting of Nuclear Factor {kappa}B Pathways by Dehydroxymethylepoxyquinomicin, a Novel Inhibitor of Breast Carcinomas: Antitumor and Antiangiogenic Potential In vivo. Clin. Cancer Res. 11: 1287-1293 [Abstract] [Full Text]  
  • Riggins, R. B., Zwart, A., Nehra, R., Clarke, R. (2005). The nuclear factor {kappa}B inhibitor parthenolide restores ICI 182,780 (Faslodex; fulvestrant)-induced apoptosis in antiestrogen-resistant breast cancer cells. Molecular Cancer Therapeutics 4: 33-41 [Abstract] [Full Text]  
  • Gu, L., Zhu, N., Findley, H. W., Woods, W. G., Zhou, M. (2004). Identification and Characterization of the IKK{alpha} Promoter: POSITIVE AND NEGATIVE REGULATION BY ETS-1 AND p53, RESPECTIVELY. J. Biol. Chem. 279: 52141-52149 [Abstract] [Full Text]  
  • Kudo, Y., Guardavaccaro, D., Santamaria, P. G., Koyama-Nasu, R., Latres, E., Bronson, R., Yamasaki, L., Pagano, M. (2004). Role of F-Box Protein {beta}Trcp1 in Mammary Gland Development and Tumorigenesis. Mol. Cell. Biol. 24: 8184-8194 [Abstract] [Full Text]  
  • Jeong, S.-J., Radonovich, M., Brady, J. N., Pise-Masison, C. A. (2004). HTLV-I Tax induces a novel interaction between p65/RelA and p53 that results in inhibition of p53 transcriptional activity. Blood 104: 1490-1497 [Abstract] [Full Text]  
  • Sweeney, C., Li, L., Shanmugam, R., Bhat-Nakshatri, P., Jayaprakasan, V., Baldridge, L. A., Gardner, T., Smith, M., Nakshatri, H., Cheng, L. (2004). Nuclear Factor-{kappa}B Is Constitutively Activated in Prostate Cancer In vitro and Is Overexpressed in Prostatic Intraepithelial Neoplasia and Adenocarcinoma of the Prostate. Clin. Cancer Res. 10: 5501-5507 [Abstract] [Full Text]  
  • Amiri, K. I., Horton, L. W., LaFleur, B. J., Sosman, J. A., Richmond, A. (2004). Augmenting Chemosensitivity of Malignant Melanoma Tumors via Proteasome Inhibition: Implication for Bortezomib (VELCADE, PS-341) as a Therapeutic Agent for Malignant Melanoma. Cancer Res. 64: 4912-4918 [Abstract] [Full Text]  
  • Zelivianski, S., Glowacki, R., Lin, M.-F. (2004). Transcriptional activation of the human prostatic acid phosphatase gene by NF-{kappa}B via a novel hexanucleotide-binding site. Nucleic Acids Res 32: 3566-3580 [Abstract] [Full Text]  
  • deGraffenried, L. A., Chandrasekar, B., Friedrichs, W. E., Donzis, E., Silva, J., Hidalgo, M., Freeman, J. W., Weiss, G. R. (2004). NF-{kappa}B inhibition markedly enhances sensitivity of resistant breast cancer tumor cells to tamoxifen. Ann Oncol 15: 885-890 [Abstract] [Full Text]  
  • Holloway, J. N., Murthy, S., El-Ashry, D. (2004). A Cytoplasmic Substrate of Mitogen-Activated Protein Kinase Is Responsible for Estrogen Receptor-{alpha} Down-Regulation in Breast Cancer Cells: The Role of Nuclear Factor-{kappa}B. Mol. Endocrinol. 18: 1396-1410 [Abstract] [Full Text]  
  • Veiby, O. P., Read, M. A. (2004). Chemoresistance: Impact of Nuclear Factor (NF)-{kappa}B Inhibition by Small Interfering RNA: Commentary re J. Guo et al., Enhanced Chemosensitivity to Irinotecan by RNA Interference-Mediated Down-Regulation of the NF-{kappa}B p65 Subunit. Clin Cancer Res 2004;10:3333-3341. Clin. Cancer Res. 10: 3262-3264 [Full Text]  
  • Towne, J. E., Garka, K. E., Renshaw, B. R., Virca, G. D., Sims, J. E. (2004). Interleukin (IL)-1F6, IL-1F8, and IL-1F9 Signal through IL-1Rrp2 and IL-1RAcP to Activate the Pathway Leading to NF-{kappa}B and MAPKs. J. Biol. Chem. 279: 13677-13688 [Abstract] [Full Text]  
  • Nguyen, D. M., Chen, G. A., Reddy, R., Tsai, W., Schrump, W. D., Cole, G. Jr, Schrump, D. S. (2004). Potentiation of paclitaxel cytotoxicity in lung and esophageal cancer cells by pharmacologic inhibition of the phosphoinositide 3-kinase/protein kinase B (Akt)-mediated signaling pathway. J. Thorac. Cardiovasc. Surg. 127: 365-375 [Abstract] [Full Text]  
  • Kumar, S., Kishimoto, H., Chua, H. L., Badve, S., Miller, K. D., Bigsby, R. M., Nakshatri, H. (2003). Interleukin-1{alpha} Promotes Tumor Growth and Cachexia in MCF-7 Xenograft Model of Breast Cancer. Am. J. Pathol. 163: 2531-2541 [Abstract] [Full Text]  
  • Tergaonkar, V., Bottero, V., Ikawa, M., Li, Q., Verma, I. M. (2003). I{kappa}B Kinase-Independent I{kappa}B{alpha} Degradation Pathway: Functional NF-{kappa}B Activity and Implications for Cancer Therapy. Mol. Cell. Biol. 23: 8070-8083 [Abstract] [Full Text]  
  • Liu, H., Lee, E.-S., Gajdos, C., Pearce, S. T., Chen, B., Osipo, C., Loweth, J., McKian, K., De Los Reyes, A., Wing, L., Jordan, V. C. (2003). Apoptotic Action of 17{beta}-Estradiol in Raloxifene-Resistant MCF-7 Cells In Vitro and In Vivo. JNCI J Natl Cancer Inst 95: 1586-1597 [Abstract] [Full Text]  
  • Pratt, M. A. C., Bishop, T. E., White, D., Yasvinski, G., Menard, M., Niu, M. Y., Clarke, R. (2003). Estrogen Withdrawal-Induced NF-{kappa}B Activity and Bcl-3 Expression in Breast Cancer Cells: Roles in Growth and Hormone Independence. Mol. Cell. Biol. 23: 6887-6900 [Abstract] [Full Text]  
  • Frasor, J., Danes, J. M., Komm, B., Chang, K. C. N., Lyttle, C. R., Katzenellenbogen, B. S. (2003). Profiling of Estrogen Up- and Down-Regulated Gene Expression in Human Breast Cancer Cells: Insights into Gene Networks and Pathways Underlying Estrogenic Control of Proliferation and Cell Phenotype. Endocrinology 144: 4562-4574 [Abstract] [Full Text]  
  • Romieu-Mourez, R., Kim, D. W., Shin, S. M., Demicco, E. G., Landesman-Bollag, E., Seldin, D. C., Cardiff, R. D., Sonenshein, G. E. (2003). Mouse Mammary Tumor Virus c-rel Transgenic Mice Develop Mammary Tumors. Mol. Cell. Biol. 23: 5738-5754 [Abstract] [Full Text]  
  • Park, S. W., Wei, L.-N. (2003). Regulation of c-myc Gene by Nitric Oxide via Inactivating NF-{kappa}B Complex in P19 Mouse Embryonal Carcinoma Cells. J. Biol. Chem. 278: 29776-29782 [Abstract] [Full Text]  
  • Guo, P., Fang, Q., Tao, H.-Q., Schafer, C. A., Fenton, B. M., Ding, I., Hu, B., Cheng, S.-Y. (2003). Overexpression of Vascular Endothelial Growth Factor by MCF-7 Breast Cancer Cells Promotes Estrogen-independent Tumor Growth in Vivo. Cancer Res. 63: 4684-4691 [Abstract] [Full Text]  
  • Pan, Q., Bao, L. W., Merajver, S. D. (2003). Tetrathiomolybdate Inhibits Angiogenesis and Metastasis Through Suppression of the NF{kappa}B Signaling Cascade. Mol Cancer Res 1: 701-706 [Abstract] [Full Text]  
  • Das, R., Mahabeleshwar, G. H., Kundu, G. C. (2003). Osteopontin Stimulates Cell Motility and Nuclear Factor {kappa}B-mediated Secretion of Urokinase Type Plasminogen Activator through Phosphatidylinositol 3-Kinase/Akt Signaling Pathways in Breast Cancer Cells. J. Biol. Chem. 278: 28593-28606 [Abstract] [Full Text]  
  • Benezra, M., Chevallier, N., Morrison, D. J., MacLachlan, T. K., El-Deiry, W. S., Licht, J. D. (2003). BRCA1 Augments Transcription by the NF-{kappa}B Transcription Factor by Binding to the Rel Domain of the p65/RelA Subunit. J. Biol. Chem. 278: 26333-26341 [Abstract] [Full Text]  
  • Pham, L. V., Tamayo, A. T., Yoshimura, L. C., Lo, P., Ford, R. J. (2003). Inhibition of Constitutive NF-{kappa}B Activation in Mantle Cell Lymphoma B Cells Leads to Induction of Cell Cycle Arrest and Apoptosis. J. Immunol. 171: 88-95 [Abstract] [Full Text]  
  • Pan, Q., Bao, L. W., Kleer, C. G., Brewer, G. J., Merajver, S. D. (2003). Antiangiogenic Tetrathiomolybdate Enhances the Efficacy of Doxorubicin against Breast Carcinoma. Molecular Cancer Therapeutics 2: 617-622 [Abstract] [Full Text]  
  • Karashima, T., Sweeney, P., Kamat, A., Huang, S., Kim, S. J., Bar-Eli, M., McConkey, D. J., Dinney, C. P. N. (2003). Nuclear Factor-{kappa}B Mediates Angiogenesis and Metastasis of Human Bladder Cancer through the Regulation of Interleukin-8. Clin. Cancer Res. 9: 2786-2797 [Abstract] [Full Text]  
  • Lu, M., Miller, K. D., Gokmen-Polar, Y., Jeng, M.-H., Kinch, M. S. (2003). EphA2 Overexpression Decreases Estrogen Dependence and Tamoxifen Sensitivity. Cancer Res. 63: 3425-3429 [Abstract] [Full Text]  
  • Helbig, G., Christopherson, K. W. II, Bhat-Nakshatri, P., Kumar, S., Kishimoto, H., Miller, K. D., Broxmeyer, H. E., Nakshatri, H. (2003). NF-{kappa} B Promotes Breast Cancer Cell Migration and Metastasis by Inducing the Expression of the Chemokine Receptor CXCR4. J. Biol. Chem. 278: 21631-21638 [Abstract] [Full Text]  
  • Meldrum, K. K., Burnett, A. L., Meng, X., Misseri, R., Shaw, M. B.K., Gearhart, J. P., Meldrum, D. R. (2003). Liposomal Delivery of Heat Shock Protein 72 Into Renal Tubular Cells Blocks Nuclear Factor-{kappa}B Activation, Tumor Necrosis Factor-{alpha} Production, and Subsequent Ischemia-Induced Apoptosis. Circ. Res. 92: 293-299 [Abstract] [Full Text]  
  • Tsai, P.-W., Shiah, S.-G., Lin, M.-T., Wu, C.-W., Kuo, M.-L. (2003). Up-regulation of Vascular Endothelial Growth Factor C in Breast Cancer Cells by Heregulin-beta 1. A CRITICAL ROLE OF p38/NUCLEAR FACTOR-kappa B SIGNALING PATHWAY. J. Biol. Chem. 278: 5750-5759 [Abstract] [Full Text]  
  • Bayon, Y., Ortiz, M. A., Lopez-Hernandez, F. J., Gao, F., Karin, M., Pfahl, M., Piedrafita, F. J. (2003). Inhibition of I{kappa}B Kinase by a New Class of Retinoid-Related Anticancer Agents That Induce Apoptosis. Mol. Cell. Biol. 23: 1061-1074 [Abstract] [Full Text]  
  • Scaife, C. L., Kuang, J., Wills, J. C., Trowbridge, D. B., Gray, P., Manning, B. M., Eichwald, E. J., Daynes, R. A., Kuwada, S. K. (2002). Nuclear Factor {kappa}B Inhibitors Induce Adhesion-dependent Colon Cancer Apoptosis: Implications for Metastasis. Cancer Res. 62: 6870-6878 [Abstract] [Full Text]  
  • Poulaki, V., Mitsiades, C. S., Joussen, A. M., Lappas, A., Kirchhof, B., Mitsiades, N. (2002). Constitutive Nuclear Factor-{kappa}B Activity Is Crucial for Human Retinoblastoma Cell Viability. Am. J. Pathol. 161: 2229-2240 [Abstract] [Full Text]  
  • Romieu-Mourez, R., Landesman-Bollag, E., Seldin, D. C., Sonenshein, G. E. (2002). Protein Kinase CK2 Promotes Aberrant Activation of Nuclear Factor-{kappa}B, Transformed Phenotype, and Survival of Breast Cancer Cells. Cancer Res. 62: 6770-6778 [Abstract] [Full Text]  
  • Franek, W. R., Chowdary, Y. C., Lin, X., Hu, M., Miller, E. J., Kazzaz, J. A., Razzano, P., Romashko, J. III, Davis, J. M., Narula, P., Horowitz, S., Scott, W., Mantell, L. L. (2002). Suppression of Nuclear Factor-kappa B Activity by Nitric Oxide and Hyperoxia in Oxygen-resistant Cells. J. Biol. Chem. 277: 42694-42700 [Abstract] [Full Text]  
  • Uzzo, R. G., Leavis, P., Hatch, W., Gabai, V. L., Dulin, N., Zvartau, N., Kolenko, V. M. (2002). Zinc Inhibits Nuclear Factor-{kappa}B Activation and Sensitizes Prostate Cancer Cells to Cytotoxic Agents. Clin. Cancer Res. 8: 3579-3583 [Abstract] [Full Text]  
  • Pan, Q., Kleer, C. G., van Golen, K. L., Irani, J., Bottema, K. M., Bias, C., De Carvalho, M., Mesri, E. A., Robins, D. M., Dick, R. D., Brewer, G. J., Merajver, S. D. (2002). Copper Deficiency Induced by Tetrathiomolybdate Suppresses Tumor Growth and Angiogenesis. Cancer Res. 62: 4854-4859 [Abstract] [Full Text]  
  • Gu, Z., Lee, R. Y., Skaar, T. C., Bouker, K. B., Welch, J. N., Lu, J., Liu, A., Zhu, Y., Davis, N., Leonessa, F., Brunner, N., Wang, Y., Clarke, R. (2002). Association of Interferon Regulatory Factor-1, Nucleophosmin, Nuclear Factor-{kappa}B, and Cyclic AMP Response Element Binding with Acquired Resistance to Faslodex (ICI 182,780). Cancer Res. 62: 3428-3437 [Abstract] [Full Text]  
  • Mitsiades, N., Mitsiades, C. S., Poulaki, V., Chauhan, D., Richardson, P. G., Hideshima, T., Munshi, N., Treon, S. P., Anderson, K. C. (2002). Biologic sequelae of nuclear factor-kappa B blockade in multiple myeloma: therapeutic applications. Blood 99: 4079-4086 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»